Industry Research Reports
Global Bio-active Peptides Market Research Report 2026
Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 136 Pages
Report ld: 6551897
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Bio-active Peptides market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bio-active Peptides competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
The North American market for Bio-active Peptides is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Bio-active Peptides is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Bio-active Peptides include Archer Daniels Midland Company, Seagarden AS, Phermpep, Arlak Biotech, Naturade, Royal DSM, MYOS RENS Technology, Natural Factors Nutritional Products, Valio Oy, Wuhan Lullaby Pharmaceutical Chemical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Bio-active Peptides market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bio-active Peptides. The Bio-active Peptides market size, estimates, and forecasts are provided in terms of output/shipments (Ton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bio-active Peptides market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bio-active Peptides manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep
- Arlak Biotech
- Naturade
- Royal DSM
- MYOS RENS Technology
- Natural Factors Nutritional Products
- Valio Oy
- Wuhan Lullaby Pharmaceutical Chemical
- Wuhan Dahua Pharmaceutical
- Pharma Foods International
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Bio-active Peptides
- Artificial Synthesis Bio-active Peptides
Segment by Application
- Food
- Health Products
- Pharmaceutical
- Other
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Bio-active Peptides manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Bio-active Peptides production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Bio-active Peptides consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Bio-active Peptides Market Overview
1.1 Product Definition
1.2 Bio-active Peptides by Type
1.2.1 Global Bio-active Peptides Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Natural Bio-active Peptides
1.2.3 Artificial Synthesis Bio-active Peptides
1.3 Bio-active Peptides by Application
1.3.1 Global Bio-active Peptides Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Food
1.3.3 Health Products
1.3.4 Pharmaceutical
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Bio-active Peptides Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Bio-active Peptides Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Bio-active Peptides Production Estimates and Forecasts (2021–2032)
1.4.4 Global Bio-active Peptides Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Bio-active Peptides Production Market Share by Manufacturers (2021–2026)
2.2 Global Bio-active Peptides Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Bio-active Peptides, Industry Ranking, 2024 vs 2025
2.4 Global Bio-active Peptides Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Bio-active Peptides Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Bio-active Peptides, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Bio-active Peptides, Product Offerings and Applications
2.8 Global Key Manufacturers of Bio-active Peptides, Date of Entry into the Industry
2.9 Bio-active Peptides Market Competitive Situation and Trends
2.9.1 Bio-active Peptides Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Bio-active Peptides Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Bio-active Peptides Production by Region
3.1 Global Bio-active Peptides Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Bio-active Peptides Production Value by Region (2021–2032)
3.2.1 Global Bio-active Peptides Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Bio-active Peptides by Region (2027–2032)
3.3 Global Bio-active Peptides Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Bio-active Peptides Production Volume by Region (2021–2032)
3.4.1 Global Bio-active Peptides Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Bio-active Peptides by Region (2027–2032)
3.5 Global Bio-active Peptides Market Price Analysis by Region (2021–2032)
3.6 Global Bio-active Peptides Production, Value, and Year-over-Year Growth
3.6.1 North America Bio-active Peptides Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Bio-active Peptides Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Bio-active Peptides Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Bio-active Peptides Production Value Estimates and Forecasts (2021–2032)
4 Bio-active Peptides Consumption by Region
4.1 Global Bio-active Peptides Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Bio-active Peptides Consumption by Region (2021–2032)
4.2.1 Global Bio-active Peptides Consumption by Region (2021–2026)
4.2.2 Global Bio-active Peptides Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Bio-active Peptides Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Bio-active Peptides Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Bio-active Peptides Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Bio-active Peptides Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Bio-active Peptides Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Bio-active Peptides Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Bio-active Peptides Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Bio-active Peptides Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Bio-active Peptides Production by Type (2021–2032)
5.1.1 Global Bio-active Peptides Production by Type (2021–2026)
5.1.2 Global Bio-active Peptides Production by Type (2027–2032)
5.1.3 Global Bio-active Peptides Production Market Share by Type (2021–2032)
5.2 Global Bio-active Peptides Production Value by Type (2021–2032)
5.2.1 Global Bio-active Peptides Production Value by Type (2021–2026)
5.2.2 Global Bio-active Peptides Production Value by Type (2027–2032)
5.2.3 Global Bio-active Peptides Production Value Market Share by Type (2021–2032)
5.3 Global Bio-active Peptides Price by Type (2021–2032)
6 Segment by Application
6.1 Global Bio-active Peptides Production by Application (2021–2032)
6.1.1 Global Bio-active Peptides Production by Application (2021–2026)
6.1.2 Global Bio-active Peptides Production by Application (2027–2032)
6.1.3 Global Bio-active Peptides Production Market Share by Application (2021–2032)
6.2 Global Bio-active Peptides Production Value by Application (2021–2032)
6.2.1 Global Bio-active Peptides Production Value by Application (2021–2026)
6.2.2 Global Bio-active Peptides Production Value by Application (2027–2032)
6.2.3 Global Bio-active Peptides Production Value Market Share by Application (2021–2032)
6.3 Global Bio-active Peptides Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Archer Daniels Midland Company
7.1.1 Archer Daniels Midland Company Bio-active Peptides Company Information
7.1.2 Archer Daniels Midland Company Bio-active Peptides Product Portfolio
7.1.3 Archer Daniels Midland Company Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Archer Daniels Midland Company Main Business and Markets Served
7.1.5 Archer Daniels Midland Company Recent Developments/Updates
7.2 Seagarden AS
7.2.1 Seagarden AS Bio-active Peptides Company Information
7.2.2 Seagarden AS Bio-active Peptides Product Portfolio
7.2.3 Seagarden AS Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Seagarden AS Main Business and Markets Served
7.2.5 Seagarden AS Recent Developments/Updates
7.3 Phermpep
7.3.1 Phermpep Bio-active Peptides Company Information
7.3.2 Phermpep Bio-active Peptides Product Portfolio
7.3.3 Phermpep Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Phermpep Main Business and Markets Served
7.3.5 Phermpep Recent Developments/Updates
7.4 Arlak Biotech
7.4.1 Arlak Biotech Bio-active Peptides Company Information
7.4.2 Arlak Biotech Bio-active Peptides Product Portfolio
7.4.3 Arlak Biotech Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Arlak Biotech Main Business and Markets Served
7.4.5 Arlak Biotech Recent Developments/Updates
7.5 Naturade
7.5.1 Naturade Bio-active Peptides Company Information
7.5.2 Naturade Bio-active Peptides Product Portfolio
7.5.3 Naturade Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Naturade Main Business and Markets Served
7.5.5 Naturade Recent Developments/Updates
7.6 Royal DSM
7.6.1 Royal DSM Bio-active Peptides Company Information
7.6.2 Royal DSM Bio-active Peptides Product Portfolio
7.6.3 Royal DSM Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Royal DSM Main Business and Markets Served
7.6.5 Royal DSM Recent Developments/Updates
7.7 MYOS RENS Technology
7.7.1 MYOS RENS Technology Bio-active Peptides Company Information
7.7.2 MYOS RENS Technology Bio-active Peptides Product Portfolio
7.7.3 MYOS RENS Technology Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 MYOS RENS Technology Main Business and Markets Served
7.7.5 MYOS RENS Technology Recent Developments/Updates
7.8 Natural Factors Nutritional Products
7.8.1 Natural Factors Nutritional Products Bio-active Peptides Company Information
7.8.2 Natural Factors Nutritional Products Bio-active Peptides Product Portfolio
7.8.3 Natural Factors Nutritional Products Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Natural Factors Nutritional Products Main Business and Markets Served
7.8.5 Natural Factors Nutritional Products Recent Developments/Updates
7.9 Valio Oy
7.9.1 Valio Oy Bio-active Peptides Company Information
7.9.2 Valio Oy Bio-active Peptides Product Portfolio
7.9.3 Valio Oy Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Valio Oy Main Business and Markets Served
7.9.5 Valio Oy Recent Developments/Updates
7.10 Wuhan Lullaby Pharmaceutical Chemical
7.10.1 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Company Information
7.10.2 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Product Portfolio
7.10.3 Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Wuhan Lullaby Pharmaceutical Chemical Main Business and Markets Served
7.10.5 Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
7.11 Wuhan Dahua Pharmaceutical
7.11.1 Wuhan Dahua Pharmaceutical Bio-active Peptides Company Information
7.11.2 Wuhan Dahua Pharmaceutical Bio-active Peptides Product Portfolio
7.11.3 Wuhan Dahua Pharmaceutical Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Wuhan Dahua Pharmaceutical Main Business and Markets Served
7.11.5 Wuhan Dahua Pharmaceutical Recent Developments/Updates
7.12 Pharma Foods International
7.12.1 Pharma Foods International Bio-active Peptides Company Information
7.12.2 Pharma Foods International Bio-active Peptides Product Portfolio
7.12.3 Pharma Foods International Bio-active Peptides Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Pharma Foods International Main Business and Markets Served
7.12.5 Pharma Foods International Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Bio-active Peptides Industry Chain Analysis
8.2 Bio-active Peptides Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Bio-active Peptides Production Modes and Processes
8.4 Bio-active Peptides Sales and Marketing
8.4.1 Bio-active Peptides Sales Channels
8.4.2 Bio-active Peptides Distributors
8.5 Bio-active Peptides Customer Analysis
9 Bio-active Peptides Market Dynamics
9.1 Bio-active Peptides Industry Trends
9.2 Bio-active Peptides Market Drivers
9.3 Bio-active Peptides Market Challenges
9.4 Bio-active Peptides Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Bio-active Peptides Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Bio-active Peptides Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Bio-active Peptides Production Capacity (Ton) by Manufacturers in 2025
Table 4. Global Bio-active Peptides Production by Manufacturers (Ton), 2021–2026
Table 5. Global Bio-active Peptides Production Market Share by Manufacturers (2021–2026)
Table 6. Global Bio-active Peptides Production Value by Manufacturers (US$ Million), 2021–2026
Table 7. Global Bio-active Peptides Production Value Share by Manufacturers (2021–2026)
Table 8. Global Key Players of Bio-active Peptides, Industry Ranking, 2024 vs 2025
Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Bio-active Peptides Production Value, 2025
Table 10. Global Market Bio-active Peptides Average Price by Manufacturers (US$/Ton), 2021–2026
Table 11. Global Key Manufacturers of Bio-active Peptides, Manufacturing Footprints and Headquarters
Table 12. Global Key Manufacturers of Bio-active Peptides, Product Offerings and Applications
Table 13. Global Key Manufacturers of Bio-active Peptides, Date of Entry into the Industry
Table 14. Global Bio-active Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Bio-active Peptides Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Bio-active Peptides Production Value (US$ Million) by Region (2021–2026)
Table 18. Global Bio-active Peptides Production Value Market Share by Region (2021–2026)
Table 19. Global Bio-active Peptides Production Value (US$ Million) Forecast by Region (2027–2032)
Table 20. Global Bio-active Peptides Production Value Market Share Forecast by Region (2027–2032)
Table 21. Global Bio-active Peptides Production Comparison by Region: 2021 vs 2025 vs 2032 (Ton)
Table 22. Global Bio-active Peptides Production (Ton) by Region (2021–2026)
Table 23. Global Bio-active Peptides Production Market Share by Region (2021–2026)
Table 24. Global Bio-active Peptides Production (Ton) Forecast by Region (2027–2032)
Table 25. Global Bio-active Peptides Production Market Share Forecast by Region (2027–2032)
Table 26. Global Bio-active Peptides Market Average Price (US$/Ton) by Region (2021–2026)
Table 27. Global Bio-active Peptides Market Average Price (US$/Ton) by Region (2027–2032)
Table 28. Global Bio-active Peptides Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Ton)
Table 29. Global Bio-active Peptides Consumption by Region (Ton), 2021–2026
Table 30. Global Bio-active Peptides Consumption Market Share by Region (2021–2026)
Table 31. Global Bio-active Peptides Forecasted Consumption by Region (Ton), 2027–2032
Table 32. Global Bio-active Peptides Forecasted Consumption Market Share by Region (2027–2032)
Table 33. North America Bio-active Peptides Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)
Table 34. North America Bio-active Peptides Consumption by Country (Ton), 2021–2026
Table 35. North America Bio-active Peptides Consumption by Country (Ton), 2027–2032
Table 36. Europe Bio-active Peptides Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)
Table 37. Europe Bio-active Peptides Consumption by Country (Ton), 2021–2026
Table 38. Europe Bio-active Peptides Consumption by Country (Ton), 2027–2032
Table 39. Asia Pacific Bio-active Peptides Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (Ton)
Table 40. Asia Pacific Bio-active Peptides Consumption by Region (Ton), 2021–2026
Table 41. Asia Pacific Bio-active Peptides Consumption by Region (Ton), 2027–2032
Table 42. Latin America, Middle East & Africa Bio-active Peptides Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (Ton)
Table 43. Latin America, Middle East & Africa Bio-active Peptides Consumption by Country (Ton), 2021–2026
Table 44. Latin America, Middle East & Africa Bio-active Peptides Consumption by Country (Ton), 2027–2032
Table 45. Global Bio-active Peptides Production (Ton) by Type (2021–2026)
Table 46. Global Bio-active Peptides Production (Ton) by Type (2027–2032)
Table 47. Global Bio-active Peptides Production Market Share by Type (2021–2026)
Table 48. Global Bio-active Peptides Production Market Share by Type (2027–2032)
Table 49. Global Bio-active Peptides Production Value (US$ Million) by Type (2021–2026)
Table 50. Global Bio-active Peptides Production Value (US$ Million) by Type (2027–2032)
Table 51. Global Bio-active Peptides Production Value Market Share by Type (2021–2026)
Table 52. Global Bio-active Peptides Production Value Market Share by Type (2027–2032)
Table 53. Global Bio-active Peptides Price (US$/Ton) by Type (2021–2026)
Table 54. Global Bio-active Peptides Price (US$/Ton) by Type (2027–2032)
Table 55. Global Bio-active Peptides Production (Ton) by Application (2021–2026)
Table 56. Global Bio-active Peptides Production (Ton) by Application (2027–2032)
Table 57. Global Bio-active Peptides Production Market Share by Application (2021–2026)
Table 58. Global Bio-active Peptides Production Market Share by Application (2027–2032)
Table 59. Global Bio-active Peptides Production Value (US$ Million) by Application (2021–2026)
Table 60. Global Bio-active Peptides Production Value (US$ Million) by Application (2027–2032)
Table 61. Global Bio-active Peptides Production Value Market Share by Application (2021–2026)
Table 62. Global Bio-active Peptides Production Value Market Share by Application (2027–2032)
Table 63. Global Bio-active Peptides Price (US$/Ton) by Application (2021–2026)
Table 64. Global Bio-active Peptides Price (US$/Ton) by Application (2027–2032)
Table 65. Archer Daniels Midland Company Bio-active Peptides Company Information
Table 66. Archer Daniels Midland Company Bio-active Peptides Specification and Application
Table 67. Archer Daniels Midland Company Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 68. Archer Daniels Midland Company Main Business and Markets Served
Table 69. Archer Daniels Midland Company Recent Developments/Updates
Table 70. Seagarden AS Bio-active Peptides Company Information
Table 71. Seagarden AS Bio-active Peptides Specification and Application
Table 72. Seagarden AS Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 73. Seagarden AS Main Business and Markets Served
Table 74. Seagarden AS Recent Developments/Updates
Table 75. Phermpep Bio-active Peptides Company Information
Table 76. Phermpep Bio-active Peptides Specification and Application
Table 77. Phermpep Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 78. Phermpep Main Business and Markets Served
Table 79. Phermpep Recent Developments/Updates
Table 80. Arlak Biotech Bio-active Peptides Company Information
Table 81. Arlak Biotech Bio-active Peptides Specification and Application
Table 82. Arlak Biotech Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 83. Arlak Biotech Main Business and Markets Served
Table 84. Arlak Biotech Recent Developments/Updates
Table 85. Naturade Bio-active Peptides Company Information
Table 86. Naturade Bio-active Peptides Specification and Application
Table 87. Naturade Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 88. Naturade Main Business and Markets Served
Table 89. Naturade Recent Developments/Updates
Table 90. Royal DSM Bio-active Peptides Company Information
Table 91. Royal DSM Bio-active Peptides Specification and Application
Table 92. Royal DSM Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 93. Royal DSM Main Business and Markets Served
Table 94. Royal DSM Recent Developments/Updates
Table 95. MYOS RENS Technology Bio-active Peptides Company Information
Table 96. MYOS RENS Technology Bio-active Peptides Specification and Application
Table 97. MYOS RENS Technology Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 98. MYOS RENS Technology Main Business and Markets Served
Table 99. MYOS RENS Technology Recent Developments/Updates
Table 100. Natural Factors Nutritional Products Bio-active Peptides Company Information
Table 101. Natural Factors Nutritional Products Bio-active Peptides Specification and Application
Table 102. Natural Factors Nutritional Products Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 103. Natural Factors Nutritional Products Main Business and Markets Served
Table 104. Natural Factors Nutritional Products Recent Developments/Updates
Table 105. Valio Oy Bio-active Peptides Company Information
Table 106. Valio Oy Bio-active Peptides Specification and Application
Table 107. Valio Oy Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 108. Valio Oy Main Business and Markets Served
Table 109. Valio Oy Recent Developments/Updates
Table 110. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Company Information
Table 111. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Specification and Application
Table 112. Wuhan Lullaby Pharmaceutical Chemical Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 113. Wuhan Lullaby Pharmaceutical Chemical Main Business and Markets Served
Table 114. Wuhan Lullaby Pharmaceutical Chemical Recent Developments/Updates
Table 115. Wuhan Dahua Pharmaceutical Bio-active Peptides Company Information
Table 116. Wuhan Dahua Pharmaceutical Bio-active Peptides Specification and Application
Table 117. Wuhan Dahua Pharmaceutical Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 118. Wuhan Dahua Pharmaceutical Main Business and Markets Served
Table 119. Wuhan Dahua Pharmaceutical Recent Developments/Updates
Table 120. Pharma Foods International Bio-active Peptides Company Information
Table 121. Pharma Foods International Bio-active Peptides Specification and Application
Table 122. Pharma Foods International Bio-active Peptides Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 123. Pharma Foods International Main Business and Markets Served
Table 124. Pharma Foods International Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Bio-active Peptides Distributors List
Table 128. Bio-active Peptides Customers List
Table 129. Bio-active Peptides Market Trends
Table 130. Bio-active Peptides Market Drivers
Table 131. Bio-active Peptides Market Challenges
Table 132. Bio-active Peptides Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bio-active Peptides
Figure 2. Global Bio-active Peptides Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Bio-active Peptides Market Share by Type: 2025 vs 2032
Figure 4. Natural Bio-active Peptides Product Picture
Figure 5. Artificial Synthesis Bio-active Peptides Product Picture
Figure 6. Global Bio-active Peptides Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Bio-active Peptides Market Share by Application: 2025 vs 2032
Figure 8. Food
Figure 9. Health Products
Figure 10. Pharmaceutical
Figure 11. Other
Figure 12. Global Bio-active Peptides Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Bio-active Peptides Production Value (US$ Million), 2021–2032
Figure 14. Global Bio-active Peptides Production Capacity (Ton), 2021–2032
Figure 15. Global Bio-active Peptides Production (Ton), 2021–2032
Figure 16. Global Bio-active Peptides Average Price (US$/Ton), 2021–2032
Figure 17. Bio-active Peptides Report Years Considered
Figure 18. Bio-active Peptides Production Share by Manufacturers in 2025
Figure 19. Global Bio-active Peptides Production Value Share by Manufacturers (2025)
Figure 20. Bio-active Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Top 5 and Top 10 Global Players: Market Share by Bio-active Peptides Revenue in 2025
Figure 22. Global Bio-active Peptides Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 23. Global Bio-active Peptides Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 24. Global Bio-active Peptides Production Comparison by Region: 2021 vs 2025 vs 2032 (Ton)
Figure 25. Global Bio-active Peptides Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 26. North America Bio-active Peptides Production Value (US$ Million) Growth Rate (2021–2032)
Figure 27. Europe Bio-active Peptides Production Value (US$ Million) Growth Rate (2021–2032)
Figure 28. China Bio-active Peptides Production Value (US$ Million) Growth Rate (2021–2032)
Figure 29. Japan Bio-active Peptides Production Value (US$ Million) Growth Rate (2021–2032)
Figure 30. Global Bio-active Peptides Consumption by Region: 2021 vs 2025 vs 2032 (Ton)
Figure 31. Global Bio-active Peptides Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 32. North America Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 33. North America Bio-active Peptides Consumption Market Share by Country (2021–2032)
Figure 34. U.S. Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 35. Canada Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 36. Europe Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 37. Europe Bio-active Peptides Consumption Market Share by Country (2021–2032)
Figure 38. Germany Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 39. France Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 40. U.K. Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 41. Italy Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 42. Russia Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 43. Asia Pacific Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 44. Asia Pacific Bio-active Peptides Consumption Market Share by Region (2021–2032)
Figure 45. China Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 46. Japan Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 47. South Korea Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 48. China Taiwan Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 49. Southeast Asia Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 50. India Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 51. Latin America, Middle East & Africa Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 52. Latin America, Middle East & Africa Bio-active Peptides Consumption Market Share by Country (2021–2032)
Figure 53. Mexico Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 54. Brazil Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 55. Turkey Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 56. GCC Countries Bio-active Peptides Consumption and Growth Rate (Ton), 2021–2032
Figure 57. Global Production Market Share of Bio-active Peptides by Type (2021–2032)
Figure 58. Global Production Value Market Share of Bio-active Peptides by Type (2021–2032)
Figure 59. Global Bio-active Peptides Price (US$/Ton) by Type (2021–2032)
Figure 60. Global Production Market Share of Bio-active Peptides by Application (2021–2032)
Figure 61. Global Production Value Market Share of Bio-active Peptides by Application (2021–2032)
Figure 62. Global Bio-active Peptides Price (US$/Ton) by Application (2021–2032)
Figure 63. Bio-active Peptides Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Bio-active Peptides market?
The top companies in the global Bio-active Peptides market are Archer Daniels Midland Company、Seagarden AS、Phermpep.
Related Reports
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-active Peptides was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 143
USD 3950.00
(Single User License)
Global Bio-active Peptides Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bio-active Peptides market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 157
USD 4900.00
(Single User License)
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-active Peptides was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 114
USD 3950.00
(Single User License)
Global Bio-active Peptides Market Research Report 2025
The global market for Bio-active Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 96
USD 2900.00
(Single User License)
Global Bio-active Peptides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-active Peptides market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 91
USD 4250.00
(Single User License)
Global Bio-active Peptides Market Insights, Forecast to 2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-04-08
Pages: 113
USD 4900.00
(Single User License)
Bio-active Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-02-22
Pages: 122
USD 3950.00
(Single User License)
Global Bio-active Peptides Market Research Report 2024
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published Date: 2024-01-16
Pages: 100
USD 2900.00
(Single User License)
Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bio-active Peptides was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 143
USD 3950.00 (Single User License)Global Bio-active Peptides Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Bio-active Peptides market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 157
USD 4900.00 (Single User License)Bio-active Peptides- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bio-active Peptides was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 114
USD 3950.00 (Single User License)Global Bio-active Peptides Market Research Report 2025
The global market for Bio-active Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 96
USD 2900.00 (Single User License)Global Bio-active Peptides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bio-active Peptides market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 91
USD 4250.00 (Single User License)Global Bio-active Peptides Market Insights, Forecast to 2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-04-08
Pages: 113
USD 4900.00 (Single User License)Bio-active Peptides - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-02-22
Pages: 122
USD 3950.00 (Single User License)Global Bio-active Peptides Market Research Report 2024
Bio-active peptides are organic substances formed by amino acids joined by covalent bonds known as amide or peptide bonds. Although some BP exist free in its natural source, the vast majority of known BP are encrypted in the structure of the parent proteins and are released mainly by enzymatic processes.
Published: 2024-01-16
Pages: 100
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now